Daily Medication Pearl: Solriamfetol (Sunosi) for Excessive Daytime Sleepiness

Article

The mechanism of action of solriamfetol is mediated through its activity as a dopamine and norepinephrine reuptake inhibitor indicated for excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.

Medication Pearl of the Day: Solriamfetol (Sunosi)

Indication: Solriamfetol is a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA).

Insight:

  • Dosing: Starting dose for patients with narcolepsy is 75 mg once daily. Starting dose for patients with OSA is 37.5 mg once daily. Dose may be increased at intervals of at least 3 days. Maximum dose is 150 mg once daily.
  • Dosage form: Tablets 75 mg (functionally scored) and 150 mg.
  • Adverse events (AEs): Most common AEs are headache, nausea, decreased appetite, insomnia, and anxiety.
  • Mechanism of action: The mechanism of action of solriamfetol is thought to be mediated through its activity as a dopamine and DNRI.
  • Manufacturer: Jazz Pharmaceuticals

Sources:

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit: Sergey | stock.adobe.com - Unhappy woman with insomnia lying on bed next to alarm clock at night
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.